Additionally, a recent report on the gastrointestinal peptides proguanylin (GUCA2A) and prouroguanylin (GUCA2B), which play major roles in obesity and satiety, demonstrated a protective effect against lipotoxicity and mitochondrial dysfunction. The gene discussed is GUCA2B; the disease is obesity disorder.